GMP IPO Watch logo GMP IPO Watch
Exchange Traded Funds (ETFs) - Other ETF

Motilal Oswal BSE Healthcare ETF

Motilal Oswal Mutual Fund

Risk: Very High Risk
52W Low ₹41.39 29 Jan 2026 52W High ₹52.93 23 Sept 2026
₹50.6356 NAV as of 6 Oct 2026 +1.12% day change
ISININF247L01BB1
Scheme Code150445
StructureOpen Ended Schemes
Fund HouseMotilal Oswal Asset Management Company Limited
AUM (avg. July - September 2026)₹44.15 Cr
Expense Ratio (as of 1 Oct 2026)0.36%
Min. Investment₹500
Inception Date14 Jul 2022
Portfolio Turnover63.03%

Returns

1Y +13.63%
3Y +21.21%
Since Inception +20.19%

Annualised (CAGR) returns for periods over a year.

Want to invest in this fund?

Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.

Open Free Account

Rank in Category

PeriodThis FundCategory Avg.Rank
1W -3.48% -0.93% 230 of 235
1M -3.11% -4.79% 35 of 235
3M -1.27% -4.32% 43 of 233
6M +19.53% +4.76% 14 of 224
YTD +13.18% -5.00% 6 of 235
1Y +13.63% +0.75% 15 of 192
2Y +6.74% +1.28% 18 of 151
3Y +21.21% +10.10% 7 of 123
INCEPTION +20.19% — —

Ranked among: Exchange Traded Funds (ETFs) - Other ETF.

Rolling Returns

PeriodAverageBestWorstPositive PeriodsConsistency
3M +5.68% +26.54% -13.52% 71% 29%
6M +11.48% +33.62% -11.41% 72% 31%
1Y +25.69% +64.22% -3.90% 94% 44%
2Y +25.50% +41.43% +6.52% 100% 48%
3Y +24.30% +28.44% +20.87% 100% 49%

Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.

NAV History

AUM Trend (₹ Cr, quarterly average)

Expense Ratio Trend

Portfolio · Aug 2026

Asset Allocation

  • Equity99.90%
  • Debt0.00%
  • Cash0.10%
  • Other0.00%

Market Cap Split

  • Large Cap34.91%
  • Mid Cap38.82%
  • Small Cap26.17%
  • Others0.10%

Fundamentals

FundCategory
P/E40.26—
P/B5.68—
Price / Sales5.85—
Price / Cash Flow30.73—
Dividend Yield (%)0.55—
Holdings125
Top 5 Stocks35.17%
Top 10 Stocks54.45%
Top 3 Sectors99.90%

Holdings · Aug 2026

HoldingSectorWeightChange (1M)
Sun Pharmaceutical Pharmaceuticals & Biotechnology 12.92% -0.40%
Divis Laboratories Pharmaceuticals & Biotechnology 7.21% +0.84%
Apollo Hospitals Equity 5.53% -0.14%
Cipla Pharmaceuticals & Biotechnology 4.90% -0.27%
Max Healthcare Institute Equity 4.61% -0.43%
Laurus Labs Pharmaceuticals & Biotechnology 4.47% +0.15%
Torrent Pharmaceuticals Pharmaceuticals & Biotechnology 4.35% -0.17%
Dr Reddys Laboratories Pharmaceuticals & Biotechnology 4.34% +0.00%
Lupin Pharmaceuticals & Biotechnology 3.23% -0.40%
Fortis Healthcare Equity 2.89% -0.16%
Aurobindo Pharma Pharmaceuticals & Biotechnology 2.88% +0.15%
Glenmark Pharmaceuticals Pharmaceuticals & Biotechnology 2.28% +0.21%
Alkem Laboratories Pharmaceuticals & Biotechnology 1.92% -0.17%
Zydus Life Science Pharmaceuticals & Biotechnology 1.79% +0.03%
Biocon Pharmaceuticals & Biotechnology 1.77% -0.11%
View all 126 holdings
IPCA Laboratories Pharmaceuticals & Biotechnology 1.69% +0.18%
Mankind Pharma Pharmaceuticals & Biotechnology 1.64% -0.07%
Gland Pharma Pharmaceuticals & Biotechnology 1.40% +0.17%
Aster DM Quality Care Equity 1.22% -0.13%
Sai Life Sciences Pharmaceuticals & Biotechnology 1.21% +0.10%
Neuland Laboratories Pharmaceuticals & Biotechnology 1.21% +0.20%
Krishna Institute of Medical Sciences Equity 1.14% -0.10%
Acutaas Chemicals Pharmaceuticals & Biotechnology 1.00% +0.01%
Wockhardt Pharmaceuticals & Biotechnology 0.95% -0.06%
Ajanta Pharma Pharmaceuticals & Biotechnology 0.94% +0.03%
Dr. Lal Path Labs Equity 0.92% +0.01%
Piramal Pharma Pharmaceuticals & Biotechnology 0.82% +0.06%
Narayana Hrudayalaya Equity 0.81% -0.06%
Abbott Pharmaceuticals & Biotechnology 0.81% -0.07%
Global Health Equity 0.78% +0.03%
Anthem Biosciences Pharmaceuticals & Biotechnology 0.77% +0.07%
GlaxoSmithKline Pharmaceuticals Pharmaceuticals & Biotechnology 0.76% +0.09%
Granules Pharmaceuticals & Biotechnology 0.73% +0.00%
Onesource Specialty Pharma Pharmaceuticals & Biotechnology 0.72% -0.06%
Shilpa Medicare Pharmaceuticals & Biotechnology 0.68% +0.23%
Eris Lifesciences Pharmaceuticals & Biotechnology 0.48% -0.03%
Natco Pharma Pharmaceuticals & Biotechnology 0.47% -0.05%
Syngene International Equity 0.46% +0.01%
Vijaya Diagnostic Centre Equity 0.45% +0.05%
Cohance Lifesciences Pharmaceuticals & Biotechnology 0.45% +0.03%
Rainbow Childrens Medicare Equity 0.44% -0.04%
Pfizer Pharmaceuticals & Biotechnology 0.43% -0.02%
Jubilant Pharmova Pharmaceuticals & Biotechnology 0.43% -0.03%
Marksans Pharma Pharmaceuticals & Biotechnology 0.42% +0.08%
Strides Pharma Science Pharmaceuticals & Biotechnology 0.42% +0.00%
Poly Medicure Equity 0.40% +0.00%
Indegene Equity 0.39% +0.06%
Emcure Pharmaceuticals Pharmaceuticals & Biotechnology 0.39% -0.02%
Metropolis Healthcare Equity 0.38% +0.00%
Rubicon Research Pharmaceuticals & Biotechnology 0.35% +0.06%
Jupiter Life Line Hospital Equity 0.34% -0.04%
Caplin Point Laboratories Pharmaceuticals & Biotechnology 0.30% -0.01%
Concord Biotech Pharmaceuticals & Biotechnology 0.30% +0.01%
Alembic Pharmaceuticals Pharmaceuticals & Biotechnology 0.28% +0.01%
Procter & Gamble Health Pharmaceuticals & Biotechnology 0.28% -0.05%
Aarti Pharma Labs Pharmaceuticals & Biotechnology 0.27% +0.06%
AstraZeneca Pharma Pharmaceuticals & Biotechnology 0.27% -0.04%
Alivus Life Sciences Pharmaceuticals & Biotechnology 0.26% +0.04%
Yatharth Hospital Equity 0.26% +0.04%
Bliss GVS Pharma Pharmaceuticals & Biotechnology 0.25% +0.06%
Viyash Scientific Pharmaceuticals & Biotechnology 0.25% +0.01%
Dr. Agarwal's Health Care Equity 0.24% +0.01%
Healthcare Global Enterprises Equity 0.24% +0.02%
Thyrocare Technologies Equity 0.23% +0.01%
Morepen Laboratories Pharmaceuticals & Biotechnology 0.23% +0.11%
Senores Pharmaceuticals Pharmaceuticals & Biotechnology 0.22% +0.02%
Suven Life Sciences Equity 0.18% +0.04%
Sanofi Pharmaceuticals & Biotechnology 0.17% -0.01%
Kovai Medical Center Hospital Equity 0.17% +0.00%
Sanofi Consumer Healthcare Pharmaceuticals & Biotechnology 0.17% -0.02%
Akums Drugs & Pharma Pharmaceuticals & Biotechnology 0.16% +0.02%
IOL Chemicals & Pharmaceuticals Pharmaceuticals & Biotechnology 0.14% +0.04%
Supriya Lifescience Pharmaceuticals & Biotechnology 0.13% -0.01%
Blue Jet Healthcare Pharmaceuticals & Biotechnology 0.12% -0.01%
Sun Pharma Advanced Research Co Pharmaceuticals & Biotechnology 0.12% +0.00%
Innova Captab Pharmaceuticals & Biotechnology 0.11% +0.01%
FDC Pharmaceuticals & Biotechnology 0.10% -0.02%
Park Medi World Equity 0.10% +0.00%
Indraprastha Medical Corporation Equity 0.10% +0.00%
Artemis Medicare Services Equity 0.10% +0.01%
Net Receivables / (Payables) Net Current Assets 0.10% —
Nephrocare Health Services Equity 0.09% +0.00%
Kwality Pharmaceuticals Pharmaceuticals & Biotechnology 0.09% +0.02%
Orchid Pharma Pharmaceuticals & Biotechnology 0.09% +0.00%
Solara Active Pharma Sciences Pharmaceuticals & Biotechnology 0.09% +0.02%
Aarti Drugs Pharmaceuticals & Biotechnology 0.09% +0.00%
Advanced Enzyme Tech Pharmaceuticals & Biotechnology 0.08% -0.01%
Gujarat Themis Biosyn Pharmaceuticals & Biotechnology 0.08% +0.01%
Corona Remedies Pharmaceuticals & Biotechnology 0.08% +0.00%
Dishman Carbogen Amcis Pharmaceuticals & Biotechnology 0.07% +0.00%
Unichem Laboratories Pharmaceuticals & Biotechnology 0.07% +0.00%
RPG Life Sciences Pharmaceuticals & Biotechnology 0.07% +0.00%
Gufic BioSciences Pharmaceuticals & Biotechnology 0.07% +0.00%
Novartis Pharmaceuticals & Biotechnology 0.07% +0.00%
SMS Pharmaceuticals Pharmaceuticals & Biotechnology 0.07% +0.00%
Krsnaa Diagnostics Equity 0.06% +0.00%
Vimta Labs Equity 0.06% +0.00%
Indoco Remedies Pharmaceuticals & Biotechnology 0.05% +0.00%
Syncom Formulations Pharmaceuticals & Biotechnology 0.05% +0.01%
Fischer Medical Ventures Equity 0.05% -0.01%
Hester Biosciences Pharmaceuticals & Biotechnology 0.05% -0.01%
Sigachi Industries Pharmaceuticals & Biotechnology 0.05% +0.01%
Windlas Biotech Pharmaceuticals & Biotechnology 0.05% +0.01%
Hikal Pharmaceuticals & Biotechnology 0.05% +0.00%
3B BlackBio DX Equity 0.04% +0.00%
Suraksha Diagnostic Equity 0.04% +0.01%
Dr. Agrawals Eye Hospital Equity 0.04% +0.00%
Panacea Biotec Pharmaceuticals & Biotechnology 0.04% +0.00%
Kopran Pharmaceuticals & Biotechnology 0.04% +0.01%
Lincoln Pharmaceuticals Pharmaceuticals & Biotechnology 0.04% +0.01%
KMC Speciality Hospitals Equity 0.03% +0.00%
Tarsons Products Equity 0.03% +0.00%
Wanbury Pharmaceuticals & Biotechnology 0.03% -0.01%
Fermenta Biotech Pharmaceuticals & Biotechnology 0.03% +0.00%
Jagsonpal Pharmaceuticals Pharmaceuticals & Biotechnology 0.03% +0.00%
GPT Healthcare Equity 0.03% +0.00%
Shalby Equity 0.03% +0.00%
Bajaj HealthCare Pharmaceuticals & Biotechnology 0.02% -0.01%
Laxmi Dental Equity 0.02% +0.00%
Gujarat Kidney and Super Speciality Equity 0.02% +0.00%
Themis Medicare Pharmaceuticals & Biotechnology 0.02% +0.00%
Anuh Pharma Pharmaceuticals & Biotechnology 0.01% +0.00%
Health X Platform Equity 0.01% +0.00%
Shree Ganesh Remedies Pharmaceuticals & Biotechnology 0.01% +0.00%
Fabtech Technologies Equity 0.01% +0.00%
Nectar Lifesciences Pharmaceuticals & Biotechnology 0.01% +0.00%

Sector Allocation · Aug 2026

Risk Metrics

Standard Deviation

PeriodFundCategory
1Y 17.07 14.22 High Volatility
3Y 16.51 16.08 High Volatility
What is this?

Risk as measured by standard deviation is a statistical measure that quantifies the amount of variation or dispersion in a set of data points relative to its mean (average).

Sharpe Ratio

PeriodFundCategory
1Y 0.73 1.00 Poor Risk Adjusted Returns
3Y 0.87 0.94 Poor Risk Adjusted Returns
What is this?

Higher the value means that fund has been able to give better returns for the amount of risk taken. It helps investors understand the return of an investment compared to its risk, showing whether the returns are due to intelligent investing or simply taking on excess risk. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the standard deviation of returns.

Sortino Ratio

PeriodFundCategory
1Y 1.19 1.82 Poor Risk Adjusted Returns
3Y 1.47 1.63 Poor Risk Adjusted Returns
What is this?

The Sortino Ratio is a financial metric used to measure the risk-adjusted return of an investment. It's a modification of the Sharpe Ratio but with a key difference; it only considers downside risk (the risk of negative returns), rather than total volatility. This means it focuses on how well an investment performs relative to the volatility that leads to losses, ignoring the volatility that results in gains. The idea is that investors are primarily concerned with minimizing losses, and positive volatility is generally seen as a good thing.

Beta

PeriodFundCategory
1Y 1.01 0.94 Poor Risk Adjusted Returns
3Y 1.00 0.95 Poor Risk Adjusted Returns
What is this?

This value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market.

Tracking Difference

1Y-0.24%
3Y-0.32%
Since Inception-0.33%

Versus BSE Health Care - TRI, as of Aug 2026.

Compare With Peers

Scheme 1Y3Y5YSince Inception
Tata Silver Exchange Traded Fund
+54.78% — — +50.51%
ICICI PRUDENTIAL SILVER ETF
+52.40% +47.61% — +29.58%
Kotak Silver ETF
+52.29% +47.52% — +35.10%
SBI Silver ETF
Regular Plan · Growth
+52.16% — — +47.07%
Edelweiss Silver ETF
+52.00% — — +45.57%
Nippon India Silver ETF
Direct Plan
+51.90% +47.19% — +30.64%
Motilal Oswal Silver ETF
+51.57% — — +76.32%
HDFC Silver ETF
Growth Option
+51.56% +47.81% — +41.06%
Zerodha Silver ETF
Direct Plan
+50.95% — — +67.53%
Motilal Oswal Nasdaq Q50 ETF
+40.73% +32.02% — +13.87%

More From Motilal Oswal Asset Management Company Limited

Scheme 1Y3Y5YSince Inception
Motilal Oswal Silver ETF
+51.57% — — +76.32%
Motilal Oswal Nasdaq 100 Fund of Fund
Direct plan · Growth
+41.16% +38.90% +24.55% +27.08%
Motilal Oswal Nasdaq Q50 ETF
+40.73% +32.02% — +13.87%
Motilal Oswal Nasdaq 100 ETF
+33.73% +33.90% +21.91% +23.84%
Motilal Oswal Gold and Silver Passive Fund of Funds
Direct Plan · Growth
+31.75% +38.49% — +32.35%
Motilal Oswal Active Momentum Fund
Direct Plan · Reinvestment/Payout
+26.04% — — +27.23%
Motilal Oswal Gold ETF
+24.99% — — +39.39%
Motilal Oswal Focused Fund
Direct Plan · Growth
+24.86% +14.61% +10.34% +14.65%
Motilal Oswal S&P 500 Index Fund
Direct Plan · GROWTH
+24.35% +27.72% +18.70% +21.32%
Motilal Oswal Developed Market Ex US ETFs Overseas Equity Passive FOF
Direct Plan · Growth
+23.27% +23.10% — +23.05%

About This Scheme

Investment Objective

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the S&P BSE Healthcare Total Return Index, subject to tracking error. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.

Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.

Market Closed · Opens 9:15 AM
NSE BSE NFO BFO CDS BCD MCX NSCOM